Effects of Social Media Usage on Pain Catastrophizing and Disease Impact in Female Patients With Fibromyalgia Syndrome

Sponsor
Uskudar State Hospital (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05883215
Collaborator
Basaksehir Cam & Sakura Şehir Hospital (Other), Sultan Abdulhamid Han Training and Research Hospital, Istanbul, Turkey (Other)
73
14

Study Details

Study Description

Brief Summary

The aim of this study is to investigate the effects of social media usage on pain catastrophizing and disease impact in female individuals diagnosed with fibromyalgia syndrome.

Condition or Disease Intervention/Treatment Phase
  • Other: Pain catastrophizing scale
  • Other: Beck Anxiety Inventory
  • Other: Social Media Use Integration Scale
  • Other: Fibromyalgia Impact Questionnaire

Detailed Description

In this study, the total number of female patients obtained as a result of sample size calculations was 73, and the effect of social media use on pain catastrophizing and disease impact of patients diagnosed with fibromyalgia will be investigated. Social media use will be evaluated with the Social Media Use Integration Scale, disease impact with the Fibromyalgia Impact Questionnaire, anxiety levels with the Beck Anxiety Inventory, and pain catastrophizing level with the pain catastrophizing scale. At the same time, a form including demographic data of the patients will be filled. The results will be evaluated with the tests prescribed by the statistical expert, and correlation will be investigated.

Study Design

Study Type:
Observational [Patient Registry]
Anticipated Enrollment :
73 participants
Observational Model:
Case-Only
Time Perspective:
Prospective
Official Title:
Effects of Social Media Usage on Pain Catastrophizing and Disease Impact in Female Patients With Fibromyalgia Syndrome
Anticipated Study Start Date :
Oct 1, 2023
Anticipated Primary Completion Date :
Jun 1, 2024
Anticipated Study Completion Date :
Dec 1, 2024

Arms and Interventions

Arm Intervention/Treatment
Female Patients Diagnosed with Fibromyalgia Syndrome

Female patients who give consent to participate and are diagnosed with fibromyalgia syndrome.

Other: Pain catastrophizing scale
The pain catastrophizing scale is a self-report questionnaire used to assess an individual's tendency to engage in catastrophic thinking when experiencing pain. It measures the extent to which a person magnifies, feels helpless, and feels unable to cope with pain. The scale typically consists of several items that ask individuals to rate the degree to which they experience specific thoughts or emotions related to pain catastrophizing, such as "I worry all the time about whether the pain will end" or "I feel like I can't stand it anymore." Participants provide responses on a Likert scale indicating the intensity or frequency of their agreement with each statement. The scale helps researchers and healthcare professionals gain insights into an individual's cognitive and emotional responses to pain, which can have implications for pain management strategies and overall well-being.

Other: Beck Anxiety Inventory
Beck Anxiety Inventory" (BAI), which is designed to measure the severity of anxiety symptoms in individuals. The BAI is a self-report questionnaire consisting of 21 items that assess various symptoms of anxiety, such as nervousness, fear, and physiological manifestations of anxiety. Participants rate the intensity of their symptoms over the past week on a scale ranging from 0 (not at all) to 3 (severely). The scores obtained on the BAI can help clinicians and researchers evaluate the presence and severity of anxiety symptoms, monitor changes over time, and guide treatment decisions. It is important to note that the BAI is not a diagnostic tool but rather a measure of self-reported anxiety symptoms.

Other: Social Media Use Integration Scale
The Social Media Use Integration Scale (SMUIS) is a self-report measure that assesses the degree to which individuals integrate social media into their daily lives. It aims to capture the extent to which individuals incorporate social media use into various aspects of their routines, behaviors, and identity. The scale typically consists of items that assess factors such as the frequency and duration of social media use, the importance and impact of social media on personal relationships, the integration of social media into daily activities, and the emotional connection to social media.

Other: Fibromyalgia Impact Questionnaire
The Fibromyalgia Impact Questionnaire (FIQ) is a widely used self-report measure specifically designed to assess the impact of fibromyalgia on various aspects of a person's life. It is a multidimensional questionnaire that evaluates the physical functioning, social functioning, and overall well-being of individuals with fibromyalgia. The FIQ typically consists of items that ask individuals to rate the impact of fibromyalgia on their ability to perform daily activities, such as work, household chores, and recreational activities. It also assesses the severity of fibromyalgia symptoms, including pain, fatigue, sleep disturbances, and cognitive difficulties. Additionally, the questionnaire may include items related to emotional well-being, social support, and overall quality of life.

Outcome Measures

Primary Outcome Measures

  1. Correlation between social media use and pain catastrophizing [1 day]

    The possible correlation between the results obtained with the social media integration scale and the results obtained with the pain catastrophizing scale will be investigated with statistical methods.

  2. Correlation between social media use and disease impact [1 day]

    The possible correlation between the results obtained with the social media integration scale and the results obtained with the fibromyalgia impact questionnaire will be investigated with statistical methods.

  3. Correlation between social media use and anxiety [1 day]

    The possible correlation between the results obtained with the social media integration scale and the results obtained with the Beck Anxiety Inventory will be investigated with statistical methods.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 65 Years
Sexes Eligible for Study:
Female
Inclusion Criteria:
  • Giving consent.

  • Being diagnosed with Fibromyalgia syndrome

  • Being female

Exclusion Criteria:
  • Not giving consent.

  • Any disability or illness that may prevent filling out the form or communicating.

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • Uskudar State Hospital
  • Basaksehir Cam & Sakura Şehir Hospital
  • Sultan Abdulhamid Han Training and Research Hospital, Istanbul, Turkey

Investigators

  • Principal Investigator: Mustafa H Temel, M.D., Uskudar State Hospital

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Mustafa Hüseyin Temel, Principal Investigator, Uskudar State Hospital
ClinicalTrials.gov Identifier:
NCT05883215
Other Study ID Numbers:
  • FMS1
First Posted:
May 31, 2023
Last Update Posted:
May 31, 2023
Last Verified:
May 1, 2023
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of May 31, 2023